The Study aims to prospectively survey the incidence of respiratory virus infections using
molecular methodologies, in children undergoing hematopoietic stem cell transplantation
Samples will be collected with a nasopharyngeal wash and processed for direct fluorescent
antibody, culture and Polymerase chain reaction (PCR)
- Age: Birth to 18 years.
- Patients undergoing an allogeneic HSCT for any disease.
- Parent or guardian willing to sign informed consent.
- Intra nasal lesion which precludes the performance of the nasopharyngeal wash.
- Patients on Continuous Positive Airway Pressure (CPAP) or Bilevel Positive Airway